Clinical trial Recruiting at 1 site Interventional Ages 35 and up

Using erythritol to improve gum health in severe periodontitis

Official title: Adjunctive Effect of Erythritol on Pocket Closure Rates: RCT

Run by University of L'Aquila · NCT06958874 · Data updated 2026-11-12

This study tests if adding erythritol powder to regular gum treatment can help people with severe periodontitis improve their gum health.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages35 Years and up
SexAll
Enrollment56 (estimated)
SponsorUniversity of L'Aquila
Academic / other
Locations1 site (L’Aquila)
StatusRecruiting
StartedNovember 8, 2024
Main results expectedMarch 31, 2025
Study endsDecember 31, 2025
Registry record updatedMay 6, 2025
Trial IDNCT06958874 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with stage 3 or 4 periodontitis and having at least 12 natural teeth.

Probably not a fit

Patients with uncontrolled systemic diseases, recent periodontal treatment, or those who smoke heavily may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of erythritol powder during non-surgical periodontal treatment for patients with severe periodontitis. Participants with gum pockets of 4 mm or more will receive either standard treatment or standard treatment combined with erythritol cleaning. The study aims to evaluate improvements in gum health indicators such as pocket depth, bleeding, and plaque levels over a period of 2 to 4 months. Factors like age, sex, smoking status, and diabetes will also be assessed for their influence on treatment outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to better gum health and healing for patients suffering from severe periodontitis.

How similar studies have gone: While the use of erythritol in periodontal treatment is relatively novel, similar studies have shown promising results with other adjunctive therapies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18 years or older

Diagnosed with stage 3 or 4 periodontitis according to the 2017 classification

Presence of at least 12 natural teeth

Presence of periodontal pockets with probing depth ≥ 4 mm in non-adjacent teeth

Good general health or stable systemic conditions (e.g., controlled diabetes)

Exclusion Criteria:

Use of antibiotics or anti-inflammatory drugs within 3 months prior to treatment

Periodontal treatment in the previous 6 months

Pregnancy or breastfeeding

Current smokers of more than 10 cigarettes per day

Allergies or intolerance to erythritol or any materials used in the treatment

Systemic diseases or conditions that could influence periodontal healing (e.g., uncontrolled diabetes, immunodeficiency)

Use of medications known to affect periodontal tissues (e.g., phenytoin, cyclosporine, calcium channel blockers)

Where it's running

  • University of L'Aquila
    L’Aquila, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.